Shares of Theravance Bio Ord (TBPH) are trading 8% higher at a price of $9.36 at the time of this writing.

Theravance Bio Ord has been trading between a 52-week high of $14.91 and a 52-week low of $6.1. The stock has a market cap of $710 Million.

Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. Its purpose is to create transformational medicines to improve the lives of patients suffering from serious illnesses.

PAYO, MRNS and CLNN are among pre market gainers
Seeking Alpha 07-14-22

Royalty Pharma To Buy Royalty Interest In Trelegy Ellipta From Theravance And Innoviva
Finanz Nachrichten 07-13-22

Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests
Benzinga 07-13-22